Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gleeson

Showing results (351-360 of 396) with videos related to

Pageof 40
Sort By:
Schizophrenia Research|April 2, 2023
A randomized controlled trial of moderated online social therapy for family carers of first-episode psychosis patients in a specialist treatment settingJohn F M Gleeson, Peter Koval, Michael Zyphur, et al.
Schizophrenia Research|September 23, 2011
Depressive symptoms in first episode schizophrenia spectrum disorderS M Cotton, M Lambert, B G Schimmelmann, et al.
Irish Journal of Psychological Medicine|August 18, 2018
Using electronic medical records to determine prevalence and treatment of mental disorders in primary care: a database studyM Gleeson, A Hannigan, R Jamali, et al.
Schizophrenia Bulletin|December 2, 2011
A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-upJohn F M Gleeson, Sue M Cotton, Mario Alvarez-Jimenez, et al.
Early Intervention in Psychiatry|October 10, 2020
Positive and meaningful lives: Systematic review and meta-analysis of eudaimonic well-being in first-episode psychosisJohn F M Gleeson, Dina Eleftheriadis, Olga Santesteban-Echarri, et al.
Social Psychiatry and Psychiatric Epidemiology|March 16, 2019
A pilot digital intervention targeting loneliness in young people with psychosisMichelle H Lim, John F M Gleeson, Thomas L Rodebaugh, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signalingE M Gleeson, C J McDonnell, E E Soule, et al.
Alzheimer Disease and Associated Disorders|December 28, 1999
Outcome measures for the study of activities of daily living in vascular dementiaS Gauthier, K Rockwood, I Gélinas, et al.
The Journal of Clinical Psychiatry|March 28, 2009
A randomized controlled trial of relapse prevention therapy for first-episode psychosis patientsJohn F M Gleeson, Sue M Cotton, Mario Alvarez-Jimenez, et al.
Blood Advances|June 3, 2020
Apolipoprotein A-I enhances activated protein C cytoprotective activityEimear M Gleeson, Aisling M Rehill, Orla Willis Fox, et al.
Pageof 40

Showing results (351-360 of 396) with videos related to

Sort By:
Pageof 40
Schizophrenia Research|April 2, 2023
A randomized controlled trial of moderated online social therapy for family carers of first-episode psychosis patients in a specialist treatment settingJohn F M Gleeson, Peter Koval, Michael Zyphur, et al.
Schizophrenia Research|September 23, 2011
Depressive symptoms in first episode schizophrenia spectrum disorderS M Cotton, M Lambert, B G Schimmelmann, et al.
Irish Journal of Psychological Medicine|August 18, 2018
Using electronic medical records to determine prevalence and treatment of mental disorders in primary care: a database studyM Gleeson, A Hannigan, R Jamali, et al.
Schizophrenia Bulletin|December 2, 2011
A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-upJohn F M Gleeson, Sue M Cotton, Mario Alvarez-Jimenez, et al.
Early Intervention in Psychiatry|October 10, 2020
Positive and meaningful lives: Systematic review and meta-analysis of eudaimonic well-being in first-episode psychosisJohn F M Gleeson, Dina Eleftheriadis, Olga Santesteban-Echarri, et al.
Social Psychiatry and Psychiatric Epidemiology|March 16, 2019
A pilot digital intervention targeting loneliness in young people with psychosisMichelle H Lim, John F M Gleeson, Thomas L Rodebaugh, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signalingE M Gleeson, C J McDonnell, E E Soule, et al.
Alzheimer Disease and Associated Disorders|December 28, 1999
Outcome measures for the study of activities of daily living in vascular dementiaS Gauthier, K Rockwood, I Gélinas, et al.
The Journal of Clinical Psychiatry|March 28, 2009
A randomized controlled trial of relapse prevention therapy for first-episode psychosis patientsJohn F M Gleeson, Sue M Cotton, Mario Alvarez-Jimenez, et al.
Blood Advances|June 3, 2020
Apolipoprotein A-I enhances activated protein C cytoprotective activityEimear M Gleeson, Aisling M Rehill, Orla Willis Fox, et al.
Pageof 40